This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Toby Litovitz, MD
National Capital Poison Center Georgetown University Hospital Washington, DC

William G. Troutman, PharmD
New Mexico Poison, Drug Information and Medical Crisis Center Albuquerque

JAMA. 1984;251(5):603.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

We can assure Drs Kulig and Rumack that the patient who had convulsions for nine hours promptly received maximal therapeutic doses of four anticonvulsants as well as neuromuscular blocking agents to control the major motor activity. Indeed, it was this difficulty controlling amoxapine-induced convulsive activity with rigorous medical management that focused our attention on the problem with this drug. Unfortunately, detailed descriptions of five severe cases were deleted in the editorial process.

In the 16 months since our study ended, 18 amoxapine overdoses were reported to the National Capital Poison Center. Of these, seizures were noted in five cases (27.8%), with status epilepticus in four of these cases. One fatality occurred, two additional patients suffered permanent neurological impairment clearly caused by the amoxapine overdose (including an 18-month-old child), and one additional patient suffered a permanent frontal lobe deficit possibly related to amoxapine (other drugs were ingested). Thus, overall, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?